Can your Cancer's genes predict chemo success? new study investigates

NCT ID NCT03977233

First seen Oct 31, 2025 · Last updated Apr 28, 2026 · Updated 20 times

Summary

This study looks at how the genetic profile of pancreatic cancer affects how well it responds to a chemotherapy combination called FOLFIRINOX, given before surgery. About 45 adults with non-metastatic pancreatic cancer will participate. Researchers will take biopsies and blood samples before and after treatment to see if the cancer's genetic type changes and whether this helps make the tumor easier to remove surgically.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER RESECTABLE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center

    RECRUITING

    Chapel Hill, North Carolina, 27599, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.